Frias Jaime A. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Frias Jaime A.
See Remarks
Transactions
- Award
Common Stock
2022-03-08+7,875→ 50,659 total - Award
Stock Option (Right to Buy)
2022-03-08+60,800→ 60,800 totalExercise: $19.15Exp: 2022-03-08→ Common Stock (60,800 underlying)
Holdings
- 225,549(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F2]Includes 7,875 RSUs.
- [F3]On April 29, 2021, a Form 4 was filed, which inadvertently reported that, following a stock split related to the Issuer's IPO, the Reporting Person directly owned 42,786 shares of Common Stock. Applying the correct stock split ratio, which rounded down fractional shares, the Reporting Person indirectly owned 42,784 shares. This correction has been reflected in this filing.
- [F4]On April 29, 2021, a Form 4 was filed which inadvertently reported that, following a stock split related to the Issuer's IPO, the Reporting Person indirectly owned 225,551 shares of Common Stock. Applying the correct stock split ratio, which rounded down fractional shares, the Reporting Person indirectly owned 225,549 shares. This correction has been reflected in this filing.
- [F5]The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.